Alan Pollack, M.D., Ph.D.
- Chair, Department of Radiation Oncology/Interim Deputy Director
- Radiation Oncology
Dr. Pollack's research interests have centered on the management of prostate cancer with an emphasis on active surveillance, radiotherapy (RT), the role and length of androgen deprivation therapy (ADT), radiation dose escalation, and radiation fractionation. He also has an active programs in small molecule/gene/viral vector targeted therapy and tissue biopsy, liquid biopsy, and imaging markers of outcome. He oversees a number of active clinical trials and co-leads the genitourinary translational research program in the NRG cooperative group.